Biogen
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1978-01-01
- Employees
- 7.5K
- Market Cap
- $29.6B
- Website
- https://www.biogen.com
- Introduction
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMAD...
How Side Effects of Avonex Are Affected by Gradually Increasing to Full Dose vs Starting at Full Dose
- Conditions
- Interventions
- First Posted Date
- 2007-12-14
- Last Posted Date
- 2008-09-04
- Lead Sponsor
- Biogen
- Target Recruit Count
- 19
- Registration Number
- NCT00574041
- Locations
- 🇦🇺
Coordinating Research Site, Malvern, Victoria, Australia
Safety Study of Natalizumab to Treat Multiple Sclerosis (MS)
- Conditions
- Interventions
- First Posted Date
- 2007-11-16
- Last Posted Date
- 2014-09-09
- Lead Sponsor
- Biogen
- Target Recruit Count
- 76
- Registration Number
- NCT00559702
- Locations
- 🇺🇸
Research Site, Vienna, Virginia, United States
Phase 1 Study of BIIB022 (Anti-IGF-1R Monoclonal Antibody) in Relapsed/Refractory Solid Tumors
- First Posted Date
- 2007-11-09
- Last Posted Date
- 2017-01-09
- Lead Sponsor
- Biogen
- Target Recruit Count
- 40
- Registration Number
- NCT00555724
- Locations
- 🇺🇸
Research Site, Philadelphia, Pennsylvania, United States
The Effects of Tysabri Treatment on Vaccination Response and Lymphocyte Subsets in Subjects With Relapsing Forms of Multiple Sclerosis
- Conditions
- Interventions
- First Posted Date
- 2007-09-27
- Last Posted Date
- 2017-02-15
- Lead Sponsor
- Biogen
- Target Recruit Count
- 60
- Registration Number
- NCT00536120
- Locations
- 🇺🇸
Research Site 4, Charleston, West Virginia, United States
🇺🇸Research Site 3, Charlotte, North Carolina, United States
🇺🇸Research Site 1, Fullerton, California, United States
Does Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a?
- Conditions
- Interventions
- First Posted Date
- 2007-09-24
- Last Posted Date
- 2007-12-13
- Lead Sponsor
- Biogen
- Target Recruit Count
- 284
- Registration Number
- NCT00534261
- Locations
- 🇬🇧
Coordinating Research Site, Glasgow, Scotland, United Kingdom
Using PET Scans to Study Brain Receptor Occupancy of BIIB014 in Healthy Male Volunteers
- First Posted Date
- 2007-09-18
- Last Posted Date
- 2008-07-30
- Lead Sponsor
- Biogen
- Target Recruit Count
- 32
- Registration Number
- NCT00531193
- Locations
- 🇬🇧
Research Site, London, United Kingdom
Avonex 15 Year Long Term Follow-up Study
- Conditions
- First Posted Date
- 2007-09-05
- Last Posted Date
- 2010-03-08
- Lead Sponsor
- Biogen
- Target Recruit Count
- 122
- Registration Number
- NCT00525343
- Locations
- 🇺🇸
Georgetown University Medical Center, Washington, District of Columbia, United States
🇺🇸Cleveland Clinic Foundation, Cleveland, Ohio, United States
🇺🇸Oregon Health and Science University, Portland, Oregon, United States
BG9924 in Combination With Methotrexate Extension of Study 104RA203 (NCT 00458861)
- First Posted Date
- 2007-08-31
- Last Posted Date
- 2016-01-21
- Lead Sponsor
- Biogen
- Target Recruit Count
- 72
- Registration Number
- NCT00523328
- Locations
- 🇬🇧
Coordinating Research Site, Newcastle, United Kingdom
Natalizumab High Titer Immunogenicity and Safety
- Conditions
- Interventions
- First Posted Date
- 2007-08-16
- Last Posted Date
- 2014-05-15
- Lead Sponsor
- Biogen
- Target Recruit Count
- 113
- Registration Number
- NCT00516893
- Locations
- 🇺🇸
Research site, Round Rock, Texas, United States
🇺🇸Research Site, Milwaukee, Wisconsin, United States
Tysabri Observational Program
- First Posted Date
- 2007-06-28
- Last Posted Date
- 2024-04-08
- Lead Sponsor
- Biogen
- Target Recruit Count
- 6620
- Registration Number
- NCT00493298
- Locations
- 🇬🇧
Research site, Stoke on Trent, United Kingdom
🇸🇰Research Site, Bratislava, Slovakia
🇫🇷Research site ,1 Allée du Château- Dr Wagner, Ars-Laquenexy, France